PHARMACOTHERAPY FOR NEONATAL DACRYOCYSTITIS

Download full text PDF
DOI: https://doi.org/None
Issue: 
5
Year: 
2015

Yu.M. Kishchenko; Professor S.A. Parfeinikov, PhD; V.L. Adzhienko, MD; T.V. Shkodina; Yu.P. Nazarenko Pyatigorsk Medical Pharmaceutical Institute, Branch, Volgograd State Medical University; 11, Kalinin Pr., Pyatigorsk 3575000

Dacryocystitis is the most common inflammatory disease in infants. It develops in most cases due to the congenitally blocked nasolacrimal duct in infants, giving rise to a bacterial inflammatory process in the conjunctiva and lacrimal sac mucosa. To restore lacrimal duct patency is a basic therapy for this disease. For this, massage of the lacrimal sac is used in infants during the first months of life and, if it is ineffective, nasolacrimal duct probing is done. If the procedures used are ineffective, antibiotic therapy is used. The paper evaluates the efficiency of antibiotic therapy for dacryocystitis in babies younger than 1 year old.
Keywords: 
dacryocystitis
antibiotic therapy
References: 
  1. Brzheskiy V.V., Chistyakova M.N., Kalinina I.V. Taktika lecheniya stenozov nososleznogo protoka u detey. H Vseros. shkola oftal`mologa: Sb. nauch. tr. M., 2011; 389–396.
  2. Ermolaev A.V., Ermolaev S.V. Sostoyanie i perspektivy razvitiya detskoy oftal`mologii. Fundam. issl., 2008; 2: 94–96.
  3. Kishhenko Yu.M., Adzhienko V.L. Osobennosti farmakoterapii vospalitel`nyh zabolevaniy glaz v detskoy praktike. Aktual`nye voprosy sovremennoy mediciny. Sb. nauch. tr. Ekaterinburg, 2014; 287–289.
  4. Musina L.T., Samoylov A.N., Galeeva G. Nereshennye problemy dakriocistita novorozhdennyh. Kazanskiy med. zhurn., 2009; 90 (6): 871–876.
  5. Osokina Yu.Yu. Rol` mikroflory v razvitii dakriocistita novorozhdennyh: avtoref. dis. … kand. med. nauk. Krasnoyarsk; 2006; 24.
  6. Cherkunov B.F. Bolezni sleznyh organov. Samara: Perspektiva, 2001; 296.
  7. Chaudhary M., Bhattarai A., Adhikari S.K., Bhatta D.R. Bacteriology and antimicrobial susceptibility of adult chronic dacryocystitis. Nepal J. Ophthalmol., 2010; 4: 105–113